Anti-fibrotic therapies target TGF-beta pathways and myofibroblast activity

https://www.inkitt.com/lainebbna

Anti-fibrotic therapies target TGF-beta pathways and myofibroblast activity, preserving organ function during regeneration and limiting pathological remodeling.